Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
Takeuchi, Tsutomu, Tanaka, Yoshiya, Soen, Satoshi, Yamanaka, Hisashi, Yoneda, Toshiyuki, Tanaka, Sakae, Nitta, Takaya, Okubo, Naoki, Genant, Harry K, van der Heijde, DésiréeLanguage:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2018-214827
Date:
April, 2019
File:
PDF, 1.42 MB
english, 2019